Halma/£HLMA

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Halma

Halma plc is a global group of life-saving technology companies headquartered in Amersham, United Kingdom. It operates in the industrial technology sector, focusing mainly on safety, health, and environmental solutions. The company’s key segments include Process Safety,Infrastructure Safety, Medical, and Environmental & Analysis. Halma's products range from fire detection and gas monitoring systems to medical devices and water analysis equipment. It is strategically positioned to leverage technological advancements to improve safety and health outcomes worldwide. The company’s presence spans numerous countries, offering a diverse geographical footprint that supports its growth strategy and market penetration.

Ticker

£HLMA

Sector

Digital Hardware

Primary listing

LSE

Employees

9,000

Halma Metrics

BasicAdvanced
£12B
42.39
£0.78
0.63
£0.23
0.70%

What the Analysts think about Halma

Analyst ratings (Buy, Hold, Sell) for Halma stock.

Bulls say / Bears say

Halma’s $140 million purchase of CenTrak Inc broadens its medical asset-tracking presence in the US, is expected to enhance earnings immediately, and further bolsters its Medical segment (Reuters).
First-half revenues exceeded £1 billion with record adjusted operating profit over £200 million, propelled by double-digit growth in safety and environmental segments, while the company maintained its full-year targets (FT).
New CFO Carole Cran's purchase of £213,000 in Halma shares in January reflects management’s strong confidence in growth prospects and the company’s financial stability (FT).
Shares are trading at around 29 times forward earnings, close to multi-year highs, which limits valuation upside and increases risk if the market corrects (FT).
The Healthcare segment had a subdued first half, with underlying organic revenue remaining flat due to OEM destocking and cautious budgets among providers, signaling possible challenges for the Medical division (FT).
Halma completed seven acquisitions this year totaling £158 million; if expected synergies take time to materialize, the rapid deal pace could stretch integration resources and potentially reduce returns (FT).
Data summarised monthly by Lightyear AI. Last updated on 30 Aug 2025.

Halma Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Halma Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £HLMA

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs